Current and new strategies in immunotherapy for superficial bladder cancer.

MeSH Terms: Adjuvants, Immunologic, Administration, Intravesical, Administration, Oral, Antineoplastic Agents, Antineoplastic Agents, Phytogenic, Bacterial Vaccines, Carcinoma, Transitional Cell, Clinical Trials, Phase I as Topic, Clinical Trials, Phase II as Topic, Cytosine, Exotoxins, Heart Diseases, Hemocyanins, Humans, Immunologic Factors, Immunotherapy, Interferons, Interleukins, Randomized Controlled Trials as Topic, Recombinant Proteins, Transforming Growth Factor alpha, Treatment Outcome, Tumor Necrosis Factor-alpha, Urinary Bladder Neoplasms